Drug Report History #93519
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v9-FR | Version v3-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2019-11-19 (Updated) | 2019-09-10 |
| Drug Identification Number | 02381389 | 02381389 |
| Brand name | EDARBI | EDARBI |
| Common or Proper name | EDARBI | EDARBI |
| Company Name | VALEANT CANADA LP/VALEANT CANADA S.E.C. | VALEANT CANADA LP/VALEANT CANADA S.E.C. |
| Ingredients | AZILSARTAN MEDOXOMIL | AZILSARTAN MEDOXOMIL |
| Strength(s) | 40MG | 40MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 28ct | 28ct |
| ATC code | C09CA | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) (Updated) | Shortage of an active ingredient. |
| Anticipated start date | ||
| Actual start date | 2019-08-08 | 2019-08-08 |
| Estimated end date | (Updated) | 2019-09-30 |
| Actual end date | 2019-11-18 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | supplier delay (Updated) | |
| Health Canada comments |